Poll: Will You Follow the New Guidelines for Cervical Cancer Screening?
New screening guidelines for the prevention and early detection of cervical cancer are now largely based on the patient’s age, and testing for HPV DNA has now been incorporated into the screening process.
New screening guidelines for the prevention and early detection of cervical cancer are now largely based on the patient’s age, and testing for HPV DNA has now been incorporated into the screening process. The new recommendations are:
No screening before the age of 21.
Pap every 3 years from age 21 – 29, but no HPV screening.
Pap and HPV testing every 5 years from age 30 – 65.
Benefits to these new guidelines include: more time spent discussing BSE, referral for mammography, healthy diet and exercise, risky behaviors, family planning, menopausal transition, osteoporosis prevention, colorectal cancer screening, and evaluation of continence and pelvic floor functioning.
If you follow the new guidelines, will you encourage your patients to come in every year to discuss other health issues? We want to know, add your opinion to the comment box!
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
